PyroGenesis Canada Inc. (CVE:PYR), a tech stock, heated up after announcing that it has signed its first contract, and received the down payment, for an order of titanium powder
Sean Mason | April 25, 2017 | SmallCapPower
A titanium powder order continued to add heat to a red-hot tech stock Tuesday. Here’s some small stocks making big moves on Tuesday, April 25, 2017 (as of 4 pm EST):
Tech stock PyroGenesis Canada Inc. (TSXV: PYR) climbed as much as 19% before ending up 3% at $0.65 on Tuesday after announcing that, further to its press release dated March 30, 2017, it has signed its first contract, and received the down payment, for an order of titanium powder (Ti-6Al-4V) and Inconel from a multinational conglomerate. The Company added that the conglomerate’s name and origin will not be disclosed for competitive reasons.
Related: PyroGenesis Canada (TSXV: PYR) is Poised to Capitalize on 3D Printing’s Potential
As well, shares of RepliCel Life Sciences Inc. (TSXV: RP) gained 21% to $1 as the clinical stage regenerative medicine company said it has been granted a key patent in the United States (U.S. Patent No. 9,616,182) covering significant components of its multi-needle dermal injection device.
NYX Gaming Group Limited (TSXV: NYX), meanwhile, reported that fiscal 2016 revenue increased 213% to $163.7 million, while its net loss widened to $57.9 million from $8.4 million during 2015. NYX Gaming Group stock eased 14% to $1.11 following the announcement.
To find out more about PyroGenesis Canada Inc., please visit the company’s Investor Hub.
Ubika Research/SmallCapPower has received compensation from PyroGenesis Canada to provide analyst research coverage. For full disclosure please visit here >>
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
